Notably, down-regulation of USP28 correlated with high BRAF levels in 75.4% (52/69) of melanoma tumors compared with 55% (16/29) of tumors which displayed both high USP28 and high BRAF (P = 0.023 and R= −0.18; Fig. 4 E). This evidence concerns the gene BRAF and melanoma.